Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 11, 2011 - Issue 9
Submit an article Journal homepage
123
Views
39
CrossRef citations to date
0
Altmetric
Theme: Demyelinating diseases - Review

Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives

Robert Zivadinov Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, NY, USA; Buffalo Neuroimaging Analysis Center, Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 100 High St., Buffalo, NY 14203, USA; The Jacobs Neurological Institute, Department of Neurology, State University of New York, Buffalo, NY, USA;[email protected]
,
Murali Ramanathan Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY, USA; Department of Pharmaceutical Sciences, State University of New York, Buffalo, NY, USA
,
Kresimir Dolic Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, NY, USA; Buffalo Neuroimaging Analysis Center, Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 100 High St., Buffalo, NY 14203, USA; Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, NY, USA; Buffalo Neuroimaging Analysis Center, Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 100 High St., Buffalo, NY 14203, USA
,
Karen Marr Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, NY, USA; Buffalo Neuroimaging Analysis Center, Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 100 High St., Buffalo, NY 14203, USA; Buffalo Neuroimaging Analysis Center, State University of New York, Buffalo, NY, USA; Buffalo Neuroimaging Analysis Center, Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 100 High St., Buffalo, NY 14203, USA
,
Yuval Karmon The Jacobs Neurological Institute, Department of Neurology, State University of New York, Buffalo, NY, USA; Department of Neurosurgery, School of Medicine and Biomedical Sciences, Millard Fillmore Gates Hospital, Kaleida Health, State University of New York, NY, USA; The Jacobs Neurological Institute, Department of Neurology, State University of New York, Buffalo, NY, USA; Department of Neurosurgery, School of Medicine and Biomedical Sciences, Millard Fillmore Gates Hospital, Kaleida Health, State University of New York, NY, USA
,
Adnan H Siddiqui Department of Neurosurgery, School of Medicine and Biomedical Sciences, Millard Fillmore Gates Hospital, Kaleida Health, State University of New York, NY, USA; Department of Neurosurgery, School of Medicine and Biomedical Sciences, Millard Fillmore Gates Hospital, Kaleida Health, State University of New York, NY, USA
,
Ralph HB Benedict The Jacobs Neurological Institute, Department of Neurology, State University of New York, Buffalo, NY, USA; The Jacobs Neurological Institute, Department of Neurology, State University of New York, Buffalo, NY, USA
&
Bianca Weinstock-Guttman The Jacobs Neurological Institute, Department of Neurology, State University of New York, Buffalo, NY, USA; The Jacobs Neurological Institute, Department of Neurology, State University of New York, Buffalo, NY, USA
 show all
Pages 1277-1294 | Published online: 09 Jan 2014

References

  • Frohman EM, Racke MK, Raine CS. Multiple sclerosis – the plaque and its pathogenesis. N. Engl. J. Med.354(9), 942–955 (2006).
  • Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol.9(7), 727–739 (2010).
  • Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol.61(4), 288–299 (2007).
  • Weiner HL. The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease? Ann. Neurol.65(3), 239–248 (2009).
  • Ebers GC, Dyment DA. Genetics of multiple sclerosis. Semin. Neurol.18(3), 295–299 (1998).
  • Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol.47(6), 707–717 (2000).
  • Trapp BD, Ransohoff R, Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr. Opin. Neurol.12(3), 295–302 (1999).
  • Hawkes CH. Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult. Scler.13(5), 610–615 (2007).
  • Marrie RA. Environmental risk factors in multiple sclerosis aetiology. Lancet Neurol.3(12), 709–718 (2004).
  • Charcot J. [Histology of multiple sclerosis]. Gaz. Hopit. Civils Milit.41, 554–566 (1868).
  • Putnam T. The pathogenesis of multiple sclerosis, a possible vascular factor. N. Engl. J. Med.209, 786–790. (1933).
  • Putnam T, Adler A. Vascular architecture of the lesions of mutliple scelrosis. Arch. Neurol. Psychiatry38, 1–15. (1937).
  • Fog T. The topography of plaques in multiple sclerosis with special reference to cerebral plaques. Acta Neurol. Scand. Suppl.15, 1–161 (1965).
  • Haacke EM. Chronic cerebral spinal venous insufficiency in multiple sclerosis. Expert Rev. Neurother.11(1), 5–9 (2011).
  • Weir B. Multiple sclerosis – a vascular etiology? Can. J. Neurol. Sci.37(6), 745–756 (2010).
  • Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain122(Pt 1), 17–26 (1999).
  • Zamboni P, Galeotti R, Menegatti E et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry80(4), 392–399 (2009).
  • Zamboni P, Galeotti R, Menegatti E et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J. Vasc. Surg.50(6), 1348–1358 e1341–1343 (2009).
  • Zamboni P, Menegatti E, Galeotti R et al. The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis. J. Neurol. Sci.282(1–2), 21–27 (2009).
  • Al-Omari MH, Rousan LA. Internal jugular vein morphology and hemodynamics in patients with multiple sclerosis. Int. Angiol.29(2), 115–120 (2010).
  • Baracchini C, Perini P, Calabrese M, Causin F, Rinaldi F, Gallo P. No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann. Neurol.69(1), 90–99 (2011).
  • Hojnacki D, Zamboni P, Lopez-Soriano A et al. Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls. Int. Angiol.29(2), 127–139 (2010).
  • Ludyga T, Kazibudzki M, Simka M et al. Endovascular treatment for chronic cerebrospinal venous insufficiency: is the procedure safe? Phlebology25(6), 286–295 (2010).
  • Simka M, Kostecki J, Zaniewski M, Majewski E, Hartel M. Extracranial Doppler sonographic criteria of chronic cerebrospinal venous insufficiency in the patients with multiple sclerosis. Int. Angiol.29(2), 109–114 (2010).
  • Yamout B, Herlopian A, Issa Z et al. Extracranial venous stenosis is an unlikely cause of multiple sclerosis. Mult. Scler.16(11), 1341–1348 (2010).
  • Zivadinov R, Galeotti R, Hojnacki D et al. Value of MR Venography for Detection of Internal Jugular Vein Anomalies in Multiple Sclerosis: a pilot longitudinal study. AJNR32, 938–945 (2011).
  • Zivadinov R, Marr K, Cutter G et al. Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology77(2), 138–44 (2011).
  • Singh AV, Zamboni P. Anomalous venous blood flow and iron deposition in multiple sclerosis. J. Cereb. Blood Flow Metab.29(12), 1867–1878 (2009).
  • Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J. R. Soc. Med.99(11), 589–593 (2006).
  • Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ. No cerebrocervical venous congestion in patients with multiple sclerosis. Ann. Neurol.68(2), 173–183 (2010).
  • Krogias C, Schroder A, Wiendl H, Hohlfeld R, Gold R. [‘Chronic cerebrospinal venous insufficiency’ and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients]. Nervenarzt81(6), 740–746 (2010).
  • Sundstrom P, Wahlin A, Ambarki K, Birgander R, Eklund A, Malm J. Venous and cerebrospinal fluid flow in multiple sclerosis: a case–control study. Ann. Neurol.68(2), 255–259 (2010).
  • Wattjes MP, van Oosten BW, de Graaf WL et al. No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study. J. Neurol. Neurosurg. Psychiatry82(4), 429–435. (2010).
  • Zivadinov R, Lopez-Soriano A, Weinstock-Guttman B et al. Use of MR venography for characterization of the extracranial venous system in patients with multiple sclerosis and healthy control subjects. Radiology258(2), 562–570 (2011).
  • Beddy P, Geoghegan T, Ramesh N et al. Valsalva and gravitational variability of the internal jugular vein and common femoral vein: ultrasound assessment. Eur. J. Radiol.58(2), 307–309 (2006).
  • Escott EJ, Branstetter BF. It’s not a cervical lymph node, it’s a vein: CT and MR imaging findings in the veins of the head and neck. Radiographics26(5), 1501–1515 (2006).
  • Schreiber SJ, Lurtzing F, Gotze R, Doepp F, Klingebiel R, Valdueza JM. Extrajugular pathways of human cerebral venous blood drainage assessed by duplex ultrasound. J. Appl. Physiol.94(5), 1802–1805 (2003).
  • Mayer CA, Pfeilschifter W, Lorenz MW et al. The perfect crime? CCSVI not leaving a trace in MS. J. Neurol. Neurosurg. Psychiatry82(4), 436–440 (2011).
  • Centonze D, Floris R, Stefanini M et al. Proposed CCSVI criteria do not predict MS risk nor MS severity. Ann. Neurol.70(1), 52–59 (2011).
  • Zamboni P. Regarding ‘no cerebrocervical venous congestion in patients with multiple sclerosis. Intraluminal jugular septation’. Ann. Neurol.68(6), 969; author reply 970 (2010).
  • Beggs C. Multiple sclerosis appears to be associated with cerebral venous abnormalities. Ann. Neur.68(4), 560–561; author reply 561–562 (2010).
  • Zivadinov R, Ramanathan M, Dwyer M, Marr K, Benedict R, Weinstock-Guttman B. Comment on no evidence of CCSVI at multiple sclerosis onset. Ann. Neurol.69(6), 1062–1063; author reply 1063 (2011).
  • Menegatti E, Genova V, Tessari M et al. The reproducibility of colour Doppler in chronic cerebrospinal venous insufficiency associated with multiple sclerosis. Int. Angiol.29(2), 121–126 (2010).
  • Khan O, Filippi M, Freedman MS et al. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann. Neurol.67(3), 286–290 (2010).
  • Fox R. Chronic cerebrospinal venous insufficiency: have we found the cause and cure of MS? Neurology77(1), 1–4 (2011).
  • Dolic K, Marr K, Valnarov V et al. Intra- and extra-luminal structural and functional venous anomalies in multiple sclerosis, as evidenced by two non-invasive imaging techniques. AJNR (2011) (In press).
  • Zivadinov R, Dolic K, Marr K et al. Comparative study of doppler sonography and magnetic resonance venography for diagnosis of chronic cerebrospinal venous insufficiency in multiple sclerosis patients. Presented at: 1st Congress of International Society for Neurovascular Disease, Bologna, Italy, 13–15 March 2011.
  • Lee AB, Laredo J, Neville R. Embryological background of truncular venous malformation in the extracranial venous pathways as the cause of chronic cerebro spinal venous insufficiency. Int. Angiol.29(2), 95–108 (2010).
  • Doepp F, Schreiber SJ, von Munster T, Rademacher J, Klingebiel R, Valdueza JM. How does the blood leave the brain? A systematic ultrasound analysis of cerebral venous drainage patterns. Neuroradiology46(7), 565–570 (2004).
  • van Amerom JF, Vidarsson L, Wu S et al. Regional pulmonary blood flow: Comparison of dynamic contrast-enhanced MR perfusion and phase-contrast MR. Magn. Reson. Med.61(5), 1249–1254 (2009).
  • Elgersma OE, Wust AF, Buijs PC, van Der Graaf Y, Eikelboom BC, Mali WP. Multidirectional depiction of internal carotid arterial stenosis: three-dimensional time-of-flight MR angiography versus rotational and conventional digital subtraction angiography. Radiology216(2), 511–516 (2000).
  • Zamboni P, Carinci F. Face, brain, and veins: a new perspective for multiple sclerosis onset. J. Craniofac. Surg.22(1), 376 (2011).
  • Zamboni P, Galeotti R. The chronic cerebrospinal venous insufficiency syndrome. Phlebology25(6), 269–279 (2010).
  • Karmon Y, Zivadinov R, Weinstock-Guttman B et al. Multimodal diagnostic correlates between doppler sonography, catheter venography, and intravascular ultrasound in the detection of venous valve abnormalities during the Phase I PREMiSe (Prospective Randomized Endovascular Therapy in Multiple Sclerosis) study. Neurology76(Suppl. 4), A320 (2011).
  • De Scheerder I, De Man F, Herregods MC et al. Intravascular ultrasound versus angiography for measurement of luminal diameters in normal and diseased coronary arteries. Am. Heart J.127(2), 243–251 (1994).
  • Machida H, Komori Y, Ueno E et al. Spatial factors for quantifying constant flow velocity in a small tube phantom: comparison of phase-contrast cine-magnetic resonance imaging and the intraluminal Doppler guidewire method. Jpn. J. Radiol.27(9), 335–341 (2009).
  • Adams C. Perivascular iron deposition and other vascular damage in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry51, 260–265 (1988).
  • Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I. Iron deposits surrounding multiple sclerosis plaques. Arch. Pathol. Lab. Med.106(8), 397–399 (1982).
  • Levine SM, Chakrabarty A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann. NY Acad. Sci.1012, 252–266 (2004).
  • Tallantyre EC, Brookes MJ, Dixon JE, Morgan PS, Evangelou N, Morris PG. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology70(22), 2076–2078 (2008).
  • Tallantyre EC, Morgan PS, Dixon JE et al. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest. Radiol.44(9), 491–494 (2009).
  • Grabner G, Dal-Bianco A, Schernthaner M, Vass K, Lassmann H, Trattnig S. Analysis of multiple sclerosis lesions using a fusion of 3.0 T FLAIR and 7.0 T SWI phase: FLAIR SWI. J. Magn. Reson. Imaging33(3), 543–549 (2011).
  • Simka M. Blood brain barrier compromise with endothelial inflammation may lead to autoimmune loss of myelin during multiple sclerosis. Curr. Neurovasc. Res.6(2), 132–139 (2009).
  • Brenneisen P, Wenk J, Klotz LO et al. Central role of Ferrous/Ferric iron in the ultraviolet B irradiation-mediated signaling pathway leading to increased interstitial collagenase (matrix-degrading metalloprotease (MMP)-1) and stromelysin-1 (MMP-3) mRNA levels in cultured human dermal fibroblasts. J. Biol. Chem.273(9), 5279–5287 (1998).
  • Worthington V, Killestein J, Eikelenboom MJ et al. Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency. Neurology75(18), 1617–1622 (2010).
  • Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics4(3), 371–386 (2007).
  • Kalman B, Laitinen K, Komoly S. The involvement of mitochondria in the pathogenesis of multiple sclerosis. J. Neuroimmunol.188(1–2), 1–12 (2008).
  • Zivadinov R, Weinstock-Guttman B, Pirko I. Iron deposition and inflammation in multiple sclerosis. Which one comes first? BMC Neurosci.12(1), 60 (2011).
  • Zakkar M, Luong le A, Chaudhury H et al. Dexamethasone arterializes venous endothelial cells by inducing mitogen-activated protein kinase phosphatase-1: a novel antiinflammatory treatment for vein grafts? Circulation123(5), 524–532 (2011).
  • Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat. Clin. Pract. Cardiovasc. Med.6(1), 16–26 (2009).
  • Ley K, Gaehtgens P. Endothelial, not hemodynamic, differences are responsible for preferential leukocyte rolling in rat mesenteric venules. Circ. Res.69(4), 1034–1041 (1991).
  • Trapp BD, Stys PK. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol.8(3), 280–291 (2009).
  • D’Haeseleer M, Cambron M, Vanopdenbosch L, De Keyser J. Vascular aspects of multiple sclerosis. Lancet Neurol.10(7), 657–666 (2011).
  • De Keyser J, Steen C, Mostert JP, Koch MW. Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance. J. Cereb. Blood Flow Metab.28(10), 1645–1651 (2008).
  • Varga AW, Johnson G, Babb JS, Herbert J, Grossman RI, Inglese M. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis. J. Neurol. Sci.282(1–2), 28–33 (2009).
  • Adhya S, Johnson G, Herbert J et al. Pattern of hemodynamic impairment in multiple sclerosis: dynamic susceptibility contrast perfusion MR imaging at 3.0 T. Neuroimage33(4), 1029–1035 (2006).
  • Ge Y, Law M, Johnson G et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR26(6), 1539–1547 (2005).
  • Inglese M, Adhya S, Johnson G et al. Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. J. Cereb. Blood Flow Metab.28(1), 164–171 (2008).
  • Law M, Saindane AM, Ge Y et al. Microvascular abnormality in relapsing–remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology231(3), 645–652 (2004).
  • Wuerfel J, Paul F, Zipp F. Cerebral blood perfusion changes in multiple sclerosis. J. Neurol. Sci.259(1–2), 16–20 (2007).
  • Zamboni P, Menegatti E, Weinstock-Guttman B et al. Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report. BMC Med.9, 22 (2011).
  • Zamboni P, Galeotti R, Weinstock-Guttman B, Kennedy C, Salvi F, Zivadinov R. Venous angioplasty in patients with multiple sclerosis. Results of a non-ranomized pilot study. Eur. J. Vasc. Endovasc. Surg. (2011) (In press).
  • Malagoni AM, Galeotti R, Menegatti E et al. Is chronic fatigue the symptom of venous insufficiency associated with multiple sclerosis? A longitudinal pilot study. Int. Angiol.29(2), 176–182 (2010).
  • Bergan JJ, Schmid-Schonbein GW, Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. N. Engl. J. Med.355(5), 488–498 (2006).
  • Tan IL, van Schijndel RA, Pouwels PJ et al. MR venography of multiple sclerosis. AJNR21(6), 1039–1042 (2000).
  • Ge Y, Zohrabian VM, Grossman RI. Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. Arch. Neurol.65(6), 812–816 (2008).
  • Hammond KE, Metcalf M, Carvajal L et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann. Neurol.64(6), 707–713 (2008).
  • Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC. Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR30(1), 19–30 (2009).
  • Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn. Reson. Med.52(3), 612–618 (2004).
  • Ge Y, Zohrabian VM, Osa EO et al. Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J. Magn. Reson. Imaging29(5), 1190–1194 (2009).
  • Zivadinov R, Poloni G, Schirda C et al. Presence and severity of chronic cerebral spinal venous insufficiency is related to lower brain parenchyma venous vasculature visibility on susceptibility-weighted imaging in patients with multiple sclerosis. Mult. Scler.16(10), (2010).
  • Meyer-Schwickerath R, Haug C, Hacker A et al. Intracranial venous pressure is normal in patients with multiple sclerosis. Mult. Scler.17(5), 637–638 (2011).
  • Zamboni P, Menegatti E, Weinstock-Guttman B et al. The severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis is related to altered cerebrospinal fluid dynamics. Funct. Neurol.24(3), 133–138 (2009).
  • Kim J, Thacker N, Bromiley P, Jackson A. Prediction of the jugular venous waveform using a model of CSF dynamics. AJNR28(5), 983–989 (2007).
  • Higgins J, Owler B, Cousins C, Pickard J. Venous sinus stenting for refractory benign intracranial hypertension. Lancet359(9302), 228–230 (2002).
  • Cutler R, Page L, Galicich J, Watters G. Formation and absorption of cerebrospinal fluid in man. Brain91(4), 707–720 (1968).
  • Lorenzo A, Page L, Watters G. Relationship between cerebrospinal fluid formation, absorption and pressure in human hydrocephalus. Brain93(4), 679–692 (1970).
  • Ascherio A, Munch M. Epstein–Barr virus and multiple sclerosis. Epidemiology11(2), 220–224 (2000).
  • Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann. Neurol.59(3), 499–503 (2006).
  • Haahr S, Hollsberg P. Multiple sclerosis is linked to Epstein–Barr virus infection. Rev. Med. Virol.16(5), 297–310 (2006).
  • Salvetti M, Giovannoni G, Aloisi F. Epstein–Barr virus and multiple sclerosis. Curr. Opin. Neurol.22(3), 201–206 (2009).
  • Lang HL, Jacobsen H, Ikemizu S et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol.3(10), 940–943 (2002).
  • Pender MP. Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol.24(11), 584–588 (2003).
  • Magliozzi R, Howell O, Vora A et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain130(Pt 4), 1089–1104 (2007).
  • Serafini B, Rosicarelli B, Franciotta D et al. Dysregulated Epstein–Barr virus infection in the multiple sclerosis brain. J. Exp. Med.204(12), 2899–2912 (2007).
  • Serafini B, Severa M, Columba-Cabezas S et al. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J. Neuropathol. Exp. Neurol.69(7), 677–693 (2010).
  • Mashav N, Saar N, Chundadze T, Steinvil A, Justo D. Epstein–Barr virus-associated venous thromboembolism: a case report and review of the literature. Thromb. Res.122(4), 570–571 (2008).
  • Jones K, Rivera C, Sgadari C et al. Infection of human endothelial cells with Epstein–Barr virus. J. Exp. Med.182(5), 1213–1221 (1995).
  • Yamazaki M, Asakura H, Kawamura Y, Ohka T, Endo M, Matsuda T. Transient lupus anticoagulant induced by Epstein–Barr virus infection. Blood Coagul. Fibrinolysis2(6), 771–774 (1991).
  • Dalpke AH, Thomssen R, Ritter K. Oxidative injury to endothelial cells due to Epstein-Barr virus-induced autoantibodies against manganese superoxide dismutase. J. Med Virol.71(3), 408–416 (2003).
  • Lipton HL, Liang Z, Hertzler S, Son KN. A specific viral cause of multiple sclerosis: one virus, one disease. Ann. Neurol.61(6), 514–523 (2007).
  • Weinstock-Guttman B, Cutter G, Hojnacki D et al. Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis. Mult. Scler.16(Suppl. 10), P653, S224 (2010).
  • Zivadinov R, Cutter G, Ramanathan M et al. MRI results of blinded chronic cerebrospinal venous insufficiency study in patients with multiple sclerosis, healthy controls and patients with other neurologic diseases. Mult. Scler.16(Suppl. 10), P318, S399 (2010).
  • Weinstock-Guttman B, Zivadinov R, Cutter G et al. Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients. PLoS One6(2), e16802 (2011).
  • De Jager PL, Chibnik LB, Cui J et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score. Lancet Neurol.8(12), 1111–1119 (2009).
  • Plasmati R, Pastorelli F, Fini N, Salvi F, Galeotti R, Zamboni P. Chronic cerebro-spinal venous insufficiency: report of transcranial magnetic stimulation follow-up study in a patient with multiple sclerosis. Int. Angiol.29(2), 189–192 (2010).
  • Samson K. Experimental multiple sclerosis vascular shunting procedure halted at Stanford. Ann. Neurol.67, A13–A15 (2010).
  • Reid DB. Commentary: significance of the internal jugular vein in the treatment of cerebrovascular insufficiency. J. Endovasc. Ther.18(3), 324–325 (2011).
  • Petrov I, Grozdinski L, Kaninski G, Iliev N, Iloska M, Radev A. Safety profile of endovascular treatment for chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J. Endovasc. Ther.18(3), 314–323 (2011).
  • Gold R. Oral therapies for multiple sclerosis: a review of agents in Phase III development or recently approved. CNS Drugs25(1), 37–52 (2011).
  • Tremlett H, Zhao Y, Rieckmann P, Hutchinson M. New perspectives in the natural history of multiple sclerosis. Neurology74(24), 2004–2015 (2010).
  • Vedantham S, Benenati JF, Kundu S, Black CM, Murphy KJ, Cardella JF. Interventional endovascular management of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a position statement by the Society of Interventional Radiology, endorsed by the Canadian Interventional Radiology Association. J. Vasc. Interv. Radiol.21(9), 1335–1337 (2010).
  • Rudick RA. Multiple sclerosis: is multiple sclerosis caused by venous insufficiency? Nat. Rev. Neurol.6(9), 472–474 (2010).
  • Filippi M, Rocca MA, Barkhof F et al. Multiple sclerosis and chronic cerebrospinal venous insufficiency: the neuroimaging perspective. AJNR32(3), 424–427 (2011).
  • Zlokovic BV. The blood–brain barrier in health and chronic neurodegenerative disorders. Neuron57(2), 178–201 (2008).
  • Zlokovic BV. Neurodegeneration and the neurovascular unit. Nat. Med.16(12), 1370–1371 (2010).
  • Chung C, Lin Y, Chao A et al. Jugular venous hemodynamic changes with aging. Ultrasound Med. Biol.36, 1776–1782 (2010).
  • Hill A. The environment and disease: association or causation. Proc. R. Soc. Med.58, 295–300 (1965).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.